Will high dose chemotherapy followed by autologous bone marrow transplantation supplant cranio-spinal irradiation in young children treated for medulloblastoma?
Journal of Neuro-Oncology1996Vol. 27(1), pp. 87–98
Citations Over TimeTop 1% of 1996 papers
Sophie Dupuis‐Girod, Olivier Hartmann, E Benhamou, François Doz, Françoise Méchinaud, Éric Bouffet, Carole Coze, C Kalifa
Related Papers
- → A Comprehensive Assessment of Toxicities in Patients with Central Nervous System Lymphoma Undergoing Autologous Stem Cell Transplantation Using Thiotepa, Busulfan, and Cyclophosphamide Conditioning(2016)27 cited
- → Secondary failure of platelet recovery in patients treated with high-dose thiotepa and busulfan followed by autologous stem cell transplantation(2020)7 cited
- A phase I-II study of high-dose thiotepa, busulfan and cyclophosphamide as a preparative regimen for allogeneic marrow transplantation.(1994)
- → Regimen related toxicity after thiotepa, cyclophosphamide and intravenous busulfan as conditioning for allogeneic stem cell transplantation(2005)
- → Thiotepa (Tt), Busulfan (Bu), and Clofarabine (Clo) as a Conditioning Therapy for Allogeneic Hematopoetic Stem Cell Transplant for Patients with High Risk Malignancies: Updated Response and Engraftment Data(2012)